Q1 FY2027 · ended Jul 31, 2026 · Revenue $843.00M, +0.7% YoY · Filed Sep 8, 2026
MiniMed Group, Inc. (MMED) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q1 of fiscal 2027, the quarter ended Jul 31, 2026, it reported revenue of $843.0 million and net income of $0. Free cash flow was -$90.0 million. As of Jul 31, 2026 it held $207.0 million in cash and investments and $59.0 million in total debt.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- MMED (Nasdaq), MMEDV (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Northridge, CA
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 2062583
- Former names
- MDT Sub Holdings, Inc. (until May 30, 2025)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q1 FY2027 Jul 31, 2026 |
Q4 FY2026 Apr 24, 2026 |
Q3 FY2026 Jan 23, 2026 |
|---|---|---|---|
| Revenue | $843.0M | $837.0M | $790.0M |
| Operating income | $5.0M | -$93.0M | -$100.0M |
| Net income | $0 | -$185.0M | -$119.0M |
| Diluted EPS | $0.00 | -$0.69 | -$0.47 |
| Operating cash flow | -$49.0M | -$170.0M | -$27.0M |
| Free cash flow | -$90.0M | -$226.0M | -$194.0M |
| Total assets | $4.7B | $4.6B | $4.3B |
| Total liabilities | $1.1B | $1.0B | $881.0M |
| Stockholders' equity | $3.6B | $3.6B | $3.5B |
| Cash and investments | $207.0M | $298.0M | $10.0M |
| Total debt | $59.0M | $53.0M | $61.0M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Change in control, Officer or director change, Regulation FD disclosure
|
Oct 16, 2026 | Oct 15, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Oct 13, 2026 | Oct 9, 2026 |
| 10-Q | Quarterly report | Sep 8, 2026 | Jul 31, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Sep 1, 2026 | Sep 1, 2026 |
| ARS | Annual report to shareholders | Aug 21, 2026 | Apr 24, 2026 |
| 8-K |
Current report
Officer or director change
|
Aug 5, 2026 | Jul 30, 2026 |
All 108 MiniMed Group, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.